«This may contribute to why certain patients have a decline in heart
function during chemotherapy treatment.»
Not exact matches
Additionally, due to other medical issues or poor performance status (a measure that considers a patient's quality of life and ability to
function during treatment), some stage III NSCLC patients are unable to receive the standard treatment of concurrent
chemotherapy and RT..
We also work as a consultant with your oncologist to support normal metabolism and digestion
during cancer treatment, manage side effects such as nausea or fatigue, and boost immune
function after
chemotherapy and radiation.